• Home
  • About Us
  • Services
  • Senior Staff
  • Publications
  • Contact Us
Health Economics and Outcomes Research
Selected Presentations
and Abstracts
Carl Brewer 

Beck EJ, Gaudreault M, Brewer CG, Mandalia S, Zowall H, Gilmore N, Klein M, Lalonde R, Murphy T, Piche, A, Platt R, Roy J, de la Sablonniere, Hankins C. Cost-effectiveness of HAART in Quebec , 1991-2001. Canadian Association for HIV Research (CAHR), Thirteen’s Annual Canadian Conference on HIV/AIDS Research, 13-16 May, 2004, Montreal, Quebec.

Grover SA, Zowall H, Brewer CG, Gilmore, Mukherjee J. Highly active antiretroviral therapy (HAART) for HIV infections and dyslipidemia : Estimating the impact of nelfinavir and atazanavir on cardiovascular (CVD) risk and life expectancy (LE) after adjustment for HIV related mortality. 4th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, October 13-14, 2002, Washington, D.C.

Grover SA, Brewer CG, Coupal L, Zowall H, Pradhan A. Estimating the benefits of
Antihypertensive therapy: an assessment of pressure. International Society for
Pharmacoeconomics & Outcomes Research, (ISPOR), Seventh Annual International Meeting, 19-22 May 2002, Crystal City, Arlington, VA.

Go to Publications

| About us | Services | Contact us
© Zowall Consulting 2016 - Report any problems to the webmaster